Furthermore, HOIP has been demonstrated to be essential for maintaining the proliferation levels of both mouse and human acute myeloid leukemia (AML) cells, and inhibiting LUBAC activity may represent an effective therapeutic strategy for AML in the future [121]. Here, RNF31 is linked to acute myeloid leukemia.